ZECCHINI EDWARD J 4
4 · Cryoport, Inc. · Filed Jun 12, 2026
Research Summary
AI-generated summary of this filing
Cryoport (CYRX) Chief Digital & Tech Officer Edward Zecchini Exercises, Sells
What Happened
Edward J. Zecchini, Cryoport's Chief Digital and Technology Officer, exercised a total of 35,000 stock options (35,000 shares) and promptly sold all 35,000 shares in open-market transactions. Exercises occurred on 2026-06-10 (1,400 shares) and 2026-06-11 (33,600 shares) at an exercise price of $4.80 per share (total exercise cost ≈ $168,000). The shares were sold for weighted-average prices of $15.23 (1,400 shares; proceeds ≈ $21,324) and $14.47 (33,600 shares; proceeds ≈ $486,239), for combined gross proceeds of about $507,563.
Key Details
- Transaction dates: 2026-06-10 (1,400 shares) and 2026-06-11 (33,600 shares).
- Exercise price: $4.80 per share; total exercise cost ≈ $168,000.
- Sale proceeds: weighted-average $15.23 (range $15.20–$15.26) and $14.47 (range $14.33–$14.615); combined proceeds ≈ $507,563.
- Net cash difference (proceeds minus exercise cost): roughly $339,563 (before taxes/fees).
- Filing date: 2026-06-12 covering 6/10–6/11 transactions; filing appears timely (Form 4 is typically due within 2 business days).
- Shares owned after the transactions: not specified in the provided summary of the filing.
- Footnotes: F1/F2 note weighted-average sale prices and price ranges; F3 notes the original option vesting schedule (1/12 vested monthly starting July 23, 2017). The filer also offered to provide a full breakdown of the number of shares sold at each separate price on request.
Context
This set of entries shows an option exercise followed by immediate sale of the resulting shares (commonly described as a cashless exercise or simultaneous exercise-and-sell). The filing also records administrative derivative-conversion entries at $0.00, which reflect conversion of the derivative instruments into common shares. Sales by executives are often routine liquidity events and, by themselves, do not necessarily indicate a change in view about the company's outlook.
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-06-10$4.80/sh+1,400$6,720→ 111,119 total - Sale
Common Stock
[F1]2026-06-10$15.23/sh−1,400$21,324→ 109,719 total - Exercise/Conversion
Common Stock
2026-06-11$4.80/sh+33,600$161,280→ 143,319 total - Sale
Common Stock
[F2]2026-06-11$14.47/sh−33,600$486,239→ 109,719 total - Exercise/Conversion
Stock Option (right to buy)
[F3]2026-06-10−1,400→ 33,600 totalExercise: $4.80Exp: 2027-06-23→ Common Stock (1,400 underlying) - Exercise/Conversion
Stock Option (right to buy)
[F3]2026-06-11−33,600→ 0 totalExercise: $4.80Exp: 2027-06-23→ Common Stock (33,600 underlying)
Footnotes (3)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.20 to $15.26, inclusive.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.33 to $14.615, inclusive.
- [F3]1/12 of options vested on the 23rd of each month for twelve months beginning July 23, 2017.